- Home
- CHRD vs ACLX Comparison
CHRD vs ACLX Comparison
Compare CHRD & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CHRD | ACLX |
|---|---|---|
| Founded | 2007 | 2015 |
| Country | United States | United States |
| Employees | 676 | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 6.7B |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | CHRD | ACLX |
|---|---|---|
| Price | $139.13 | $115.08 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 15 |
| Target Price | ★ $149.17 | $118.17 |
| AVG Volume (30 Days) | 621.8K | ★ 12.1M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.56% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $22,286,000.00 |
| Revenue This Year | $12.56 | $342.39 |
| Revenue Next Year | N/A | $170.71 |
| P/E Ratio | $34.53 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $84.25 | $60.36 |
| 52 Week High | $151.95 | $115.14 |
Technical Indicators
Market Signals| Indicator | CHRD | ACLX |
|---|---|---|
| Relative Strength Index (RSI) | 50.82 | 79.86 |
| Support Level | $131.54 | $63.46 |
| Resistance Level | $142.22 | N/A |
| Average True Range (ATR) | 4.51 | 0.11 |
| MACD | -0.45 | -0.62 |
| Stochastic Oscillator | 50.72 | 84.28 |
Price Performance
Historical ComparisonAbout CHRD Chord Energy Corporation
Chord Energy Corp is an independent exploration and production (E&P) company engaged in the acquisition, exploration, development and production of crude oil, NGL and natural gas prominently in the Williston Basin, with limited non-operated interests in the Marcellus Shale. It operates in one reportable business segment, which is the E&P of crude oil, NGL and natural gas. The company derives revenue from the sale of crude oil, NGL and natural gas production.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.